Yen Sang-Hue, Hsu Yi-Hsuan, Phiri Doreen, Kuo Chia-Chun, Fang Hui-Fen, Chung Min-Huey
Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
School of Nursing, Taipei Medical University, Taipei, Taiwan.
BMC Cancer. 2025 Apr 23;25(1):761. doi: 10.1186/s12885-025-13930-6.
Although research has highlighted the link between anxiety and cancer, studies on the relationship between the two have produced inconsistent findings. Therefore, we investigated this relationship and also examined which types of cancer are more likely to induce anxiety.
This retrospective longitudinal cohort study, conducted in Taiwan from 2003 to 2016, looked at the risk of cancer in 23,255 patients with anxiety disorder and the risk of anxiety in 33,334 patients with cancer diagnosed between 2003 and 2005. For both analyses, a comparison cohort was created using 1:4 case-control sampling. Cox proportional hazard regression models were used to analyze factors related to anxiety disorder or cancer.
Patients with anxiety were more likely to develop cancer (adjusted hazard ratio [AHR] = 1.29; 95% confidence interval [CI]: 1.23-1.35) compared to those in the comparison group. Particularly high risks were observed for thyroid cancer (AHR: 2.13, CI: 1.60-2.82), skin cancer (AHR: 2.10, CI: 1.63-2.71), and prostate cancer (AHR: 1.97, CI: 1.59-2.47). Patients with cancer were more likely to develop anxiety than those without cancer (AHR: 1.63, 95% CI: 1.56-1.71), with particularly high risks observed in those with nose cancer (AHR: 3.12, 95% CI: 2.41-4.03), leukemia (AHR: 2.54, 95% CI: 1.63-3.96), thyroid cancer (AHR: 2.34, 95% CI: 1.84-2.97), and oral cancer (AHR: 2.04, 95% CI: 1.65-2.52).
Our findings highlight a bidirectional link between cancer and anxiety disorder. Understanding this two-way connection can help healthcare providers develop effective strategies for managing cancer and anxiety disorders.
尽管研究强调了焦虑与癌症之间的联系,但关于两者关系的研究结果并不一致。因此,我们对这种关系进行了调查,并研究了哪些类型的癌症更有可能引发焦虑。
这项回顾性纵向队列研究于2003年至2016年在台湾进行,观察了23255名焦虑症患者患癌症的风险,以及2003年至2005年间确诊的33334名癌症患者患焦虑症的风险。对于这两项分析,均采用1:4病例对照抽样创建了一个对照队列。使用Cox比例风险回归模型分析与焦虑症或癌症相关的因素。
与对照组相比,焦虑症患者患癌症的可能性更高(调整后风险比[AHR]=1.29;95%置信区间[CI]:1.23-1.35)。甲状腺癌(AHR:2.13,CI:1.60-2.82)、皮肤癌(AHR:2.10,CI:1.63-2.71)和前列腺癌(AHR:1.97,CI:1.59-2.47)的风险尤其高。癌症患者比无癌症患者更易患焦虑症(AHR:1.63,95%CI:1.56-1.71),鼻癌患者(AHR:3.12,95%CI:2.41-4.03)、白血病患者(AHR:2.54,95%CI:1.63-3.96)、甲状腺癌患者(AHR:2.34,95%CI:1.84-2.97)和口腔癌患者(AHR:2.04,95%CI:1.65-2.52)的风险尤其高。
我们的研究结果突出了癌症与焦虑症之间的双向联系。了解这种双向联系有助于医疗服务提供者制定有效的策略来管理癌症和焦虑症。